Outpatient chemotherapy admission rates of 11 cancer hospitals
Seattle-based Fred Hutchinson Cancer Institute had the lowest admission rate for patients receiving outpatient chemotherapy of all prospective payment system-exempt cancer hospitals between July 1, 2023, and June 30, 2024.
Eleven cancer hospitals are required to participate in the PPS-Exempt Cancer Hospital Quality Reporting Program, a specialized quality reporting program established in 2010 by the ACA.
The national admission rate of outpatient chemotherapy patients for the same time period was 13. CMS measured the percentage of patients admitted to the 11 hospitals within 30 days of receiving outpatient chemotherapy treatment for all cancer types except leukemia.
Here are the 30-day admission rates of outpatient chemotherapy patients for all 11 PPS-exempt cancer hospitals:
| Facility | Rate | Total Cases |
| Fred Hutchinson Cancer Institute (Seattle) | 10.7 | 1,977 |
| Fox Chase Cancer Center (Philadelphia) | 11.3 | 445 |
| USC Kenneth Norris Jr. Cancer Hospital (Los Angeles) | 12.4 | 1,311 |
| Moffitt Cancer Center & Research Institute (Tampa, Fla.) | 12.7 | 3,357 |
| Roswell Park Cancer Institute (Buffalo, N.Y.) | 12.7 | 826 |
| University of Miami Sylvester Comprehensive Cancer Center | 12.8 | 1,549 |
| Memorial Sloan Kettering Cancer Center (New York City) | 13.2 | 8,991 |
| James Cancer Hospital and Solove Research Institute (Columbus, Ohio) | 14 | 1,875 |
| City of Hope (Duarte, Calif.) | 14.1 | 2,329 |
| University of Texas MD Anderson Cancer Center (Houston) | 14.4 | 5,788 |
| Dana-Farber Cancer Institute (Boston) | 15.1 | 4,719 |
The post Outpatient chemotherapy admission rates of 11 cancer hospitals appeared first on Becker’s Hospital Review | Healthcare News & Analysis.